EP4438121A2 — Pharmaceutical composition containing acetominophen and ibuprofen
Assigned to AFT Pharmaceuticals Ltd · Expires 2024-10-02 · 2y expired
What this patent protects
The invention is a solid oral dosage form, for example a tablet, comprising 325 mg of acetaminophen and 97.5 mg of ibuprofen, or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 2 and 8 µm, a [D10] between 1 and 3 µm, and a [D90] between …
USPTO Abstract
The invention is a solid oral dosage form, for example a tablet, comprising 325 mg of acetaminophen and 97.5 mg of ibuprofen, or 500 mg of acetaminophen and 150 mg of ibuprofen, wherein the ibuprofen has a [D50] between 2 and 8 µm, a [D10] between 1 and 3 µm, and a [D90] between 4 and 16 µm.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.